3-amino-6-methoxy-2-(1-pyrrolyl)pyridine | 160657-12-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡啶及其衍生物
• 英文名称: 3-amino-6-methoxy-2-(1-pyrrolyl)pyridine
• 英文别名: 6-Methoxy-2-pyrrol-1-ylpyridin-3-amine
• CAS: 160657-12-5
• 化学式: C₁₀H₁₁N₃O
• mdl: MFCD18711841
• 分子量: 189.217
• InChiKey: MOVCAVNVHXEYHA-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.1
• 拓扑面积：
  53.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  3-amino-6-methoxy-2-(1-pyrrolyl)pyridine 在 potassium carbonate 、 三氯氧磷 作用下， 以 N,N-二甲基甲酰胺 、 甲苯 为溶剂， 反应 4.0h， 生成 12-methoxy-N-[3-[4-[3-[(12-methoxy-2,8,13-triazatricyclo[7.4.0.02,6]trideca-1(9),3,5,7,10,12-hexaen-7-yl)amino]propyl]piperazin-1-yl]propyl]-2,8,13-triazatricyclo[7.4.0.02,6]trideca-1(9),3,5,7,10,12-hexaen-7-amine
  参考文献：
  名称：

  Synthesis, Antimalarial Activity, and Molecular Modeling of New Pyrrolo[1,2-a]quinoxalines, Bispyrrolo[1,2-a]quinoxalines, Bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and Bispyrrolo[1,2-a]thieno[3,2-e]pyrazines

  摘要：

  Three pyrrolo[1,2-a]quinoxalines, 15 bispyrrolo[1,2-a]quinoxalines, bispyrido[3,2-e]pyrrolo[1,2-a]pyrazines, and bispyrrolo[1,2-a]thieno[3,2-e]pyrazines were synthesized from various substituted nitroanilines or nitropyridines and tested for their in vitro activity upon the erythrocytic development of Plasmodium falciparum strains with different chloroquine-resistance status. Bispyrrolo[1,2-a]quinoxalines showed superior antimalarial. activity with respect to monopyrrolo[1,2-a]quinoxalines. The best activity was observed with bispyrrolo[1,2-a]quinoxalines linked by a bis(3-aminopropyl)piperazine. Moreover, it was observed that the presence of a methoxy group on the pyrrolo[1,2-a]quinoxaline nucleus increased the pharmacological activity. Drug effects upon beta-hematin formation were assayed and showed similar or higher inhibitory activities than CQ. A possible mechanism of interaction implicating binding of pyrroloquinoxalines to beta-hematin was supported by molecular modeling.

  DOI：

  10.1021/jm0310840
• 作为产物：
  描述：

  6-methoxy-3-nitro-2-(1-pyrrolyl)pyridine 在 铁粉 、 氯化铵 作用下， 以 水 为溶剂， 以670.2 mg的产率得到3-amino-6-methoxy-2-(1-pyrrolyl)pyridine
  参考文献：
  名称：

  1-(2-氨基苯基)吡咯电化学氧化脱氢环化与醚裂解合成吡咯并[1,2-a]喹喔啉衍生物

  摘要：

  通过电化学氧化还原反应，包括 C(sp 3 )–H 键的官能化以及 C–C 和 C–N 的构建，获得了一系列吡咯并[1,2- a ]喹喔啉衍生物，产率中等至良好债券。在该原子经济反应中，THF既用作反应物又用作溶剂，H 2是唯一的副产物。

  DOI：

  10.1039/d3ob01867a

文献信息

• Ruthenium-Catalyzed Synthesis of Pyrrolo[1,2-a]quinoxaline Derivatives from 1-(2-Aminophenyl)pyrroles and Sulfoxonium Ylides
  作者：Guo-Sheng Huang、Xin-Feng Cui、Fang-Peng Hu、Xiao-Qiang Zhou、Zhen-Zhen Zhan

  DOI：10.1055/s-0040-1707119

  日期：2020.7

  A ruthenium-catalyzed [5+1] annulation of 1-(2-aminophenyl)pyrroles with α-carbonyl sulfoxonium ylides is reported. This reaction provides a one-step method for synthesizing pyrrolo[1,2-a]quinoxaline derivatives under ambient conditions. The system proceeds with a short reaction time and a high functional-group tolerance. Notably, this divergent protocol tolerates β-keto sulfoxonium ylides and can

  报道了钌催化的 1-（2-氨基苯基）吡咯与 α-羰基锍叶立德的 [5+1] 环化。该反应提供了一种在环境条件下合成吡咯并[1,2-a]喹喔啉衍生物的一步法。该系统以较短的反应时间和较高的官能团耐受性进行。值得注意的是，这种不同的协议耐受 β-酮锍叶立德，并可应用于 α-酯锍叶立德。对该反应机理进行了初步研究，并提出了反应途径。
• Tricyclic pyrrolopyrazine 5-HT.sub.3 -active compounds
  申请人：Adir Et Compagnie

  公开号：US05599812A1

  公开（公告）日：1997-02-04

  The present invention relates to a compound selected from these of formula (I): ##STR1## in which A and R.sub.1 are as defined in the description, and medicinal product containing the same which is useful for treating a disorder linked to the 5-HT.sub.3 receptors.

  本发明涉及一种选择自以下化学式(I)的化合物：##STR1## 其中A和R.sub.1如描述中定义的，以及含有该化合物的药物产品，用于治疗与5-HT.sub.3受体相关的疾病。
• Dérivés de pyrrolopyrazines à activité 5-HT3
  申请人：ADIR ET COMPAGNIE

  公开号：EP0623620A1

  公开（公告）日：1994-11-09

  La présente invention concerne les composés de formule (I) : dans laquelle A et R₁ sont tels que définis dans la description. Médicaments.

  本发明涉及式（I）化合物： 其中 A 和 R₁ 如描述中所定义。 药物。
• Novel and Selective Partial Agonists of 5-HT₃ Receptors. 2. Synthesis and Biological Evaluation of Piperazinopyridopyrrolopyrazines, Piperazinopyrroloquinoxalines, and Piperazinopyridopyrroloquinoxalines
  作者：Hervé Prunier、Sylvain Rault、Jean-Charles Lancelot、Max Robba、Pierre Renard、Philippe Delagrange、Bruno Pfeiffer、Daniel-Henri Caignard、René Misslin、Béatrice Guardiola-Lemaitre, and、Michel Hamon

  DOI：10.1021/jm960501o

  日期：1997.6.1

  In continuation of our previous work on piperazinopyrrolothienopyrazine derivatives, three series of piperazinopyridopyrrolopyrazines, piperazinopyrroloquinoxalines, and piperazinopyridopyrrolaquinoxalines were prepared and evaluated as 5-HT3 receptor ligands. The chemical modifications performed within these new series led to structure-activity relationships regarding both high affinity and selectivity for the 5-HT3 receptors that are in agreement with those established previously for the pyrrolothienopyrazine series. The best compound (8a) obtained in these new series is in the picomolar range of affinity for 5-HT3 receptors with a selectivity higher than 10(6). Four of the high-affinity 5-HT3 ligands (8a, 15a,b, and 16d) were selected in both the pyridopyrrolopyrazine and the pyrroloquinoxaline series and were characterized in vitro and in vivo as agonists or partial agonists. Compound 8a was also evaluated in the light/dark test where it showed potential anxiolytic-like activity at very low doses per os.
• US5599812A
  申请人：——

  公开号：US5599812A

  公开（公告）日：1997-02-04